A total of 360 weaned pigs (DNA 200 × 400; initially 11.5 lb BW) were used in a 42-d study evaluating the effects of feeding Elarom SES in combination with high levels of ZnO and/or antimicrobials on nursery pig performance and fecal consistency. Elarom SES (Trouw Nutrition USA, Highland, IL) is a commercially available blend of short chain fatty acids (SCFAs), medium chain fatty acids (MCFAs) and slow release organic acids designed to enhance growth performance and gut health. Pigs were weaned at approximately 21 d and allotted to pens based on initial BW in a completely randomized design. Experimental treatments were arranged as a 2 × 2 × 2 factorial. The 8 treatment diets included: Elarom SES (none vs. 4 lb/ton), additional ZnO (none vs. 3,000 ppm in phase 1, 2,000 ppm in phase 2, and none in phase 3), and antimicrobial regimen (none vs. 400 g/ton CTC and 35 g/ton Denagard in Phase 1 and 50 g/ ton Mecadox in Phases 2 and 3). Experimental diets were fed in 3 phases (Phase 1, d 0 to 7; Phase 2, d 7 to 21; and Phase 3, d 21 to 42 post-weaning) and fed in meal form. Overall, an Elarom SES × ZnO × antimicrobial interaction was observed for ADG (P = 0.043) and F/G (P = 0.009). The ADG interaction was the result of poorer ADG when Elarom SES or ZnO were added alone compared to when feed antimicrobials were added alone or when Elarom SES was added in combination with ZnO or ZnO was added in combination with antimicrobials. The F/G interaction was a result of the poorest F/G observed when all three additives were added in combination, compared to the control diet with Elarom SES or antimicrobials only and the diet with Elarom SES and ZnO in combination or the diet with ZnO and antimicrobial in combination. Adding antibiotics to the diet increased (P < 0.013) ADG and ADFI, but there were no main effects of ZnO or Elarom SES observed. There were no individual or overall treatment effects (P > 0.100), or treatment × day interactions (P = 0.53) observed for fecal consistency. Overall, we observed some benefits in performance when adding combinations of ingredients compared to including them as stand alone products. More research should be conducted to confirm this response. 
Swine Day 2016 K A N S A S STAT E UNI VE R S IT Y 2016
Kansas State University Agricultural Experiment Station and Cooperative Extension Service 
Summary
A total of 360 weaned pigs (DNA 200 × 400; initially 11.5 lb BW) were used in a 42-d study evaluating the effects of feeding Elarom SES in combination with high levels of ZnO and/or antimicrobials on nursery pig performance and fecal consistency. Elarom SES (Trouw Nutrition USA, Highland, IL) is a commercially available blend of short chain fatty acids (SCFAs), medium chain fatty acids (MCFAs) and slow release organic acids designed to enhance growth performance and gut health. Pigs were weaned at approximately 21 d and allotted to pens based on initial BW in a completely randomized design. Experimental treatments were arranged as a 2 × 2 × 2 factorial. The 8 treatment diets included: Elarom SES (none vs. 4 lb/ton), additional ZnO (none vs. 3,000 ppm in phase 1, 2,000 ppm in phase 2, and none in phase 3), and antimicrobial regimen (none vs. 400 g/ton CTC and 35 g/ton Denagard in Phase 1 and 50 g/ton Mecadox in Phases 2 and 3). Experimental diets were fed in 3 phases (Phase 1, d 0 to 7; Phase 2, d 7 to 21; and Phase 3, d 21 to 42 post-weaning) and fed in meal form. Overall, an Elarom SES × ZnO × antimicrobial interaction was observed for ADG (P = 0.043) and F/G (P = 0.009). The ADG interaction was the result of poorer ADG when Elarom SES or ZnO were added alone compared to when feed antimicrobials were added alone or when Elarom SES was added in combination with ZnO or ZnO was added in combination with antimicrobials. The F/G interaction was a result of the poorest F/G observed when all three additives were added in combination, compared to the control diet with Elarom SES or antimicrobials only and the diet with Elarom SES and ZnO in combination or the diet with ZnO and antimicrobial in combination. Adding antibiotics to the diet increased (P < 0.013) ADG and ADFI, but there were no main effects of ZnO or Elarom SES observed. There were no individual or overall treatment effects (P > 0.100), or treatment × day interactions (P = 0.53) observed for fecal consistency. Overall, we observed some benefits in performance when adding combinations of ingredients compared to including them as stand alone products. More research should be conducted to confirm this response. The treatment ingredients were substituted for an equivalent amount of corn in the respective diets to form the experimental treatments (Table 1) . Pigs and feeders were weighed every 7 d to determine ADG, ADFI, and F/G.
Fecal scoring of pens occurred on d 0, 4, 7, 14, 21, 28, 35, and 42 by visual appraisal of the pen floor. Fecal scores were conducted before weighing on weigh days and were replicated by 3 individuals each day. Pens were scored on a scale from 1 to 5 with 1 indicating hard pellet type feces; 2 indicating firm, formed feces; 3 indicating soft, moist feces that retained shape; 4 indicating soft, unformed feces; and 5 indicating watery, liquid feces.
All diets were fed in meal form and were prepared at the Kansas State University O.H. Kruse Feed Technology Innovation Center in Manhattan, KS. Each diet contained 110 ppm of added Zn from ZnO from the trace mineral premix. Diet samples were collected at manufacturing, and pooled samples of each diet were submitted for analysis of DM, CP, Ca, P, and Zn (Ward Laboratories, Inc., Kearney, NE; Table 2 ). Analyzed diets confirmed diets manufactured with no added ZnO contained approximately 110 ppm ZnO from the trace mineral premix, and diets manufactured with added ZnO contained approximately 3,000 ppm ZnO in Phase 1 and approximately 2,000 ppm in Phase 2.
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Growth data were analyzed as a randomized complete block design using the PROC GLIM-MIX procedure of SAS (SAS Institute, Inc., Cary, NC) with pen as the experimental unit. The main effects of Zn, Elarom SES, and antimicrobial, as well as their interactions, were evaluated using preplanned CONTRAST statements. The main effects of Zn, Elarom SES, and antimicrobial, as well as day and treatment interactions were tested using preplanned CONTRAST statements. Fecal consistency scores were analyzed using PROC MIXED in SAS with pen as the experimental unit. The main effects of Zn, Elarom SES, and antibiotic, as well as day and treatment interactions were tested using preplanned CONTRAST statements. Differences between treatments were determined by using least squares means. A P-value ≤ 0.05 was considered significant and 0.05 < P ≤ 0.10 was considered marginally significant.
Results and Discussion
From d 0 to 7, an Elarom SES × ZnO interaction (P = 0.016) was observed for F/G (Table 3 and 4). The interaction occurred because pigs fed Elarom SES in combination with ZnO had improved F/G comparative to pigs fed diets containing only Elarom SES or ZnO with the control diet intermediate. Pigs fed diets containing feed antimicrobials had improved ADG (P = 0.047) compared to those without.
From d 7 to 21, ADG tended to be greater (P = 0.091) when diets contained Elarom SES, but ADFI and F/G were not influenced. Including ZnO in the diets increased (P < 0.001) ADG, ADFI, and d 21 BW and marginally improved (P = 0.074) F/G. Diets containing feed antimicrobials had improved (P < 0.001) ADG, ADFI, F/G, and d 21 wt.
From d 0 to 21, an Elarom SES × ZnO interaction was observed for F/G (P = 0.026) and ADG (P = 0.053). The greatest improvement in ADG and F/G was observed when both Elarom SES and ZnO were included in the diets compared to when either was added alone. Including ZnO in the diets increased (P <0.001) ADG, ADFI, and tended to improve (P = 0.071) F/G. Diets containing feed antimicrobials had improved (P < 0.001) ADG, ADFI, and F/G.
From d 21 to 42, an Elarom SES × ZnO × antimicrobial interaction tended to be observed (P = 0.055) for ADG and was observed (P = 0.006) for F/G. This interaction occurred because ADG and F/G was poorest when all three feed additives were added in combination compared to all other treatments. There was an Elarom SES × antimicrobial interaction for ADFI (P = 0.013) that was the result of ADFI being similar to control values when both additives were included; however, when only the antimicrobial was added to the diet, ADFI was increased.
Overall (from d 0 to 42), an Elarom SES × ZnO × antibiotic interaction was observed for ADG (P = 0.043) and F/G (P = 0.009). The ADG interaction was the result of poorer ADG when Elarom SES or ZnO were added alone compared to when antibiotic was added alone or when Elarom SES was added in combination with ZnO or ZnO was added in combination with antibiotic. The F/G interaction was a result of the poorest F/G being reported when all three additives were added in combination, compared to the control, diets with Elarom SES or antibiotic only and the diet with Elarom SES and ZnO in combination or the diet with ZnO and medication in combination. Overall, ADFI was increased (P < 0.001) when antibiotic was included in the diets.
While there was no treatment effect on fecal consistency, there was a day effect observed (P = 0.001; Table 5 ) resulting from d 0, 4, and 7 pigs exhibiting softer stool that improved to a firmer stool in the subsequent collection days.
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In summary, these data suggest feeding combinations of different feed additives may influence growth performance in a manner that is different than their individual performance would indicate. For instance, the combination of Elarom SES and high ZnO had performance similar to the medication treatment, even though Elarom SES or high ZnO treatments fed alone had poorer performance than the medication treatment. The main effect of medication or ZnO during the Zn feeding phase was similar to previous studies. However, we unexpectedly observed poorer performance in some diets once ZnO was removed from the diet, which warrants further investigation. Also, further research should be considered to improve the understanding of feeding Elarom SES in combination with high ZnO and medication and at what periods of the nursery phase these additives should be fed to improve growth performance. Complete diet samples were obtained from each dietary treatment during manufacturing. Samples of diets were then submitted for analysis of DM, CP, Ca, P, and Zn (Ward Laboratories, Inc., Kearney, NE). 4, 7, 14, 21, 28, 35, and 42) . Pens were scored by 3 trained individuals; those 3 scores were then averaged and reported as pen means for overall and each collection day fecal consistency. Scoring scale guidelines: 1 = dry, firm pellet; 2 = firmly formed stool; 3 = soft stool that retains shape; 4 = soft, unformed stool; and 5 = watery liquid stool. There was no overall or individual treatment effect (P > 0.100). Zinc oxide fed at 3,000 ppm in Phase 1 (d 0 to 7) and 2,000 ppm in Phase 2 (d 7 to 21). 4, 7, 14, 21, 28, 35, and 42) . Pens were scored by 3 trained individuals; those scores were then averaged and reported as pen means for each collection day. Scoring scale guidelines: 1 = dry, firm pellet; 2 = firmly formed stool; 3 = soft stool that retains shape; 4 = soft, unformed stool; and 5 = watery liquid. Treatment × Day interaction (P = 0.53) and day effect (P < 0.01).
